(Q36031229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Schizophrenia: a review of neuropharmacology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

J Lyne

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

W T O'Connor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

Irish Journal of Medical Science

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

155-159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

8 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03167931

The 100-year epidemiology of schizophrenia.

21 January 2018

1 reference

12 December 2020

Enhancement of prepulse inhibition after blockade of GABA activity within the superior colliculus

1 reference

12 December 2020

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

12 December 2020

Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

1 reference

12 December 2020

Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients

1 reference

12 December 2020

Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia

1 reference

12 December 2020

Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia

1 reference

12 December 2020

Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia

1 reference

12 December 2020

Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia

1 reference

12 December 2020

Prevalence studies in schizophrenia

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

Dopamine partial agonists: a new class of antipsychotic

1 reference

12 December 2020

Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

1 reference

12 December 2020

Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis

1 reference

12 December 2020

Partial dopamine agonists in the treatment of psychosis

1 reference

12 December 2020

Amygdaloid N-methyl-D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats.

1 reference

12 December 2020

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03167931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693386%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference